POLYCYSTIC LIVER DISEASE

Clinical trials for POLYCYSTIC LIVER DISEASE explained in plain language.

Never miss a new study

Get alerted when new POLYCYSTIC LIVER DISEASE trials appear

Sign up with your email to follow new studies for POLYCYSTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New shot aims to shrink painful, swollen livers

Disease control Ongoing

This study is testing whether a new injectable medication called CAM2029 can safely reduce liver size and ease symptoms in people with polycystic liver disease. About 71 adults with symptoms like abdominal pain, bloating, and shortness of breath will receive either the real treat…

Matched conditions: POLYCYSTIC LIVER DISEASE

Phase: PHASE2, PHASE3 • Sponsor: Camurus AB • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

POLYCYSTIC LIVER DISEASE

Get alerted when new POLYCYSTIC LIVER DISEASE trials appear

New shot aims to shrink painful, swollen livers